Mechanical Circulatory Support Devices for Acute Right Ventricular Failure

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Biomedical Engineering

Background:

• Right ventricular (RV) failure is a critical determinant of morbidity and mortality in advanced heart failure, pulmonary hypertension, and post-cardiac surgery.
• Percutaneously delivered acute mechanical circulatory support (RV MCS) devices have emerged as a key therapeutic option over the last two decades.
• RV MCS plays a crucial role in stabilizing patients experiencing cardiogenic shock involving the RV.

Purpose of the Study:

• To review the pathophysiology of acute RV failure.
• To discuss the mechanisms of action and clinical utility of current RV MCS devices.
• To highlight the evolving role of RV MCS in patient management.

Main Methods:

• Literature review of existing RV acute mechanical circulatory support devices.
• Analysis of clinical data on the efficacy and application of RV MCS.
• Discussion of the pathophysiology of acute RV failure.

Main Results:

• RV acute mechanical circulatory support is an established intervention for RV failure.
• The effectiveness of RV MCS is increasingly reliant on optimized patient selection, monitoring, and weaning protocols.
• Existing RV MCS devices offer rapid stabilization for RV cardiogenic shock.

Conclusions:

• RV MCS is an integral part of managing RV failure.
• Future advancements in RV MCS will focus on improved patient management strategies beyond technical implantation.
• Optimizing algorithms for RV failure identification, patient monitoring, and weaning protocols is essential for maximizing the benefit of RV MCS.